[1] 曾昭冲. 原发性肝癌放射治疗现状及前景[J].中国实用外科杂志,2014,34(8):699-702. [2] Wang WH,Wang Z,Wu JX,et al.Survival benefit with IMRT following narrow-margin hepatectomy in patients with hepatocellular carcinoma close to major vessels[J].Liver Int,2015,35(12):2603-2610. [3] Chen SW,Lin LC,Kuo YC,et al.Phase 2 study of combined sorafenib and radiation therapy in patients with advanced hepatocellular carcinoma[J].Int J Radiat Oncol Biol Phys,2014,88(5):1041-1047. [4] Yoon HI,Song KJ,Lee IJ,et al.Clinical benefit of hepatic arterial infusion concurrent chemoradiotherapy in locally advanced hepatocellular carcinoma:a propensity score matching analysis[J].Cancer Res Treat,2016,48(1):190-197. [5] Yao S,To KK,Wang YZ,et al.Polyoxypregnane steroids from the stems of Marsdenia tenacissima[J].J Nat Prod,2014,77(9):2044-2053. [6] 方奕奇.消癌平注射液体外作用于HEL细胞株的实验研究[D].南京:南京中医药大学,2010. [7] 马晓洁,宋明洋,谭榜宪.原发性肝癌放疗联合其他治疗的新进展[J].现代肿瘤医学,2015,23(1):139-141. [8] Wang J,Li Y,Liu Y,et al.Overexpression of truncated AIF regulated by Egr1 promoter radiation-induced apoptosis onMCF-7 cells[J].Radiat Environ Biophys,2015,54(4):413-421. [9] 王剑锋,方芳,刘扬,等.Egr1介导的人截短型凋亡诱导因子表达载体的构建及其在乳腺癌MCF-7细胞中的辐射诱导表达规律[J].吉林大学学报:医学版,2012,38(3):521-526. [10] Huang Z,Wang Y,Chen J,et al.Effect of Xiaoaiping injection on advanced hepatocellular carcinoma in patients[J].J Tradit Chin Med,2013,33(1):34-38. [11] 陶小鑫,于浩,柏建岭.消癌平注射液联合化学治疗对非小细胞肺癌的临床疗效及安全性Meta分析[J].医药导报,2014,33(1):48-53. [12] 郑爱文,李涛,陈雅卿,等.消癌平联合顺铂对高转移人卵巢癌HO-8910PM细胞的抑制作用[J].中华肿瘤杂志,2016,38(1):11-16. [13] 赵和平,梁丽群.消癌平联合奥曲肽对对Hepa1-6细胞作用的实验研究[J].中国药物与临床,2010,10(1):59-60. [14] 马安然,任宁宁,韩立博,等.基于医学数字X线影像频谱特征的图像检索[J].中国医学物理学杂志,2016,33(9):933-938. |